387 related articles for article (PubMed ID: 29603092)
1. MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.
McKeever PM; Schneider R; Taghdiri F; Weichert A; Multani N; Brown RA; Boxer AL; Karydas A; Miller B; Robertson J; Tartaglia MC
Mol Neurobiol; 2018 Dec; 55(12):8826-8841. PubMed ID: 29603092
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
Riancho J; Vázquez-Higuera JL; Pozueta A; Lage C; Kazimierczak M; Bravo M; Calero M; Gonalezález A; Rodríguez E; Lleó A; Sánchez-Juan P
J Alzheimers Dis; 2017; 57(2):483-491. PubMed ID: 28269782
[TBL] [Abstract][Full Text] [Related]
3. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
Gui Y; Liu H; Zhang L; Lv W; Hu X
Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.
Müller M; Jäkel L; Bruinsma IB; Claassen JA; Kuiperij HB; Verbeek MM
Mol Neurobiol; 2016 Jul; 53(5):2894-2899. PubMed ID: 25895659
[TBL] [Abstract][Full Text] [Related]
5. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
Dangla-Valls A; Molinuevo JL; Altirriba J; Sánchez-Valle R; Alcolea D; Fortea J; Rami L; Balasa M; Muñoz-García C; Ezquerra M; Fernández-Santiago R; Lleó A; Lladó A; Antonell A
Mol Neurobiol; 2017 Nov; 54(9):6647-6654. PubMed ID: 27738874
[TBL] [Abstract][Full Text] [Related]
6. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
Lugli G; Cohen AM; Bennett DA; Shah RC; Fields CJ; Hernandez AG; Smalheiser NR
PLoS One; 2015; 10(10):e0139233. PubMed ID: 26426747
[TBL] [Abstract][Full Text] [Related]
7. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.
Dong Z; Gu H; Guo Q; Liang S; Xue J; Yao F; Liu X; Li F; Liu H; Sun L; Zhao K
Mol Neurobiol; 2021 Jul; 58(7):3084-3094. PubMed ID: 33629272
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
Denk J; Boelmans K; Siegismund C; Lassner D; Arlt S; Jahn H
PLoS One; 2015; 10(5):e0126423. PubMed ID: 25992776
[TBL] [Abstract][Full Text] [Related]
9. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.
Li F; Xie XY; Sui XF; Wang P; Chen Z; Zhang JB
Neuroscience; 2020 Apr; 432():240-246. PubMed ID: 32135232
[TBL] [Abstract][Full Text] [Related]
10. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
Kumar S; Reddy PH
Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
[TBL] [Abstract][Full Text] [Related]
11. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation.
Lv Z; Hu L; Yang Y; Zhang K; Sun Z; Zhang J; Zhang L; Hao Y
Metab Brain Dis; 2018 Oct; 33(5):1711-1720. PubMed ID: 29961914
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study.
Schneider R; McKeever P; Kim T; Graff C; van Swieten JC; Karydas A; Boxer A; Rosen H; Miller BL; Laforce R; Galimberti D; Masellis M; Borroni B; Zhang Z; Zinman L; Rohrer JD; Tartaglia MC; Robertson J;
J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):851-858. PubMed ID: 29434051
[TBL] [Abstract][Full Text] [Related]
15. Upregulated Blood miR-150-5p in Alzheimer's Disease Dementia Is Associated with Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral Atrophy.
Chia SY; Vipin A; Ng KP; Tu H; Bommakanti A; Wang BZ; Tan YJ; Zailan FZ; Ng ASL; Ling SC; Okamura K; Tan EK; Kandiah N; Zeng L
J Alzheimers Dis; 2022; 88(4):1567-1584. PubMed ID: 35811521
[TBL] [Abstract][Full Text] [Related]
16. Exosomal microRNA profiles from serum and cerebrospinal fluid in neurosyphilis.
Chen H; Zhou Y; Wang ZY; Yan BX; Zhou WF; Wang TT; Zheng M; Man XY
Sex Transm Infect; 2019 Jun; 95(4):246-250. PubMed ID: 30926713
[TBL] [Abstract][Full Text] [Related]
17. Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer's Disease and Frontotemporal Dementia.
Tan YJ; Wong BYX; Vaidyanathan R; Sreejith S; Chia SY; Kandiah N; Ng ASL; Zeng L
J Alzheimers Dis Rep; 2021; 5(1):805-813. PubMed ID: 34870106
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Alzheimer's Disease Micro-RNA Profile in Exosome-Enriched CSF Samples.
Riancho J; Santurtun A; Sánchez-Juan P
Methods Mol Biol; 2019; 2044():343-352. PubMed ID: 31432424
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
Herrera-Espejo S; Santos-Zorrozua B; Álvarez-González P; Lopez-Lopez E; Garcia-Orad Á
Mol Neurobiol; 2019 Dec; 56(12):8376-8391. PubMed ID: 31240600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]